| Benjamin Glines I, DO | |
|
615 N Michigan St, South Bend, IN 46601-1033 | |
| (574) 647-1000 | |
| Not Available |
| Full Name | Benjamin Glines I |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 6 Years |
| Location | 615 N Michigan St, South Bend, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174017180 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 5101026354 (Michigan) | Secondary |
| 207P00000X | Emergency Medicine | 02006673A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hospital Of South Bend | South bend, IN | Hospital |
| Community Hospital Of Bremen Inc | Bremen, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Epmg Downriver Pllc | 6608038443 | 26 |
| South Bend Emergency Physicians Inc | 0941282354 | 44 |
News Archive
Cigarette smoking has been linked to acute myelogenous leukemia, according to The Health Consequences of Smoking: A Report of the Surgeon General, released today.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals International GmbH, today announced that the European Commission has granted Marketing Authorisation for Entyvio (vedolizumab), a gut-selective humanized monoclonal antibody, and the first and only biologic therapy to be approved simultaneously for the treatment of adults with moderately to severely active ulcerative colitis (UC) and adults with moderately to severely active Crohn's disease (CD) who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a tumor necrosis factor-alpha (TNFα) antagonist.
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is to establish 20 Collaborative Research Centres (CRCs) by 1 July 2012. This decision was taken by the Grants Committee at its spring session in Bonn. The new CRCs will receive funding totalling 176 million euros (including a 20 percent programme allowance for indirect project costs) for the initial 4-year funding period.
Elderly patients with limited-stage small cell lung cancer showed similar survival and toxicity compared to their younger counterparts when treated with concurrent chemo-radiotherapy. Concurrent chemo-radiotherapy should be a treatment option for fit patients aged 70 years or older.
Bayer HealthCare today announced updated data from the pivotal Phase III ALSYMPCA (ALpharadin in SYMptomatic Prostate CAncer) trial for its investigational drug radium-223 dichloride in men with castration-resistant prostate cancer (CRPC) and symptomatic bone metastases.
› Verified 3 days ago
| Entity Name | Farmington Emergency Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568496370 PECOS PAC ID: 6305732140 Enrollment ID: O20040302000665 |
News Archive
Cigarette smoking has been linked to acute myelogenous leukemia, according to The Health Consequences of Smoking: A Report of the Surgeon General, released today.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals International GmbH, today announced that the European Commission has granted Marketing Authorisation for Entyvio (vedolizumab), a gut-selective humanized monoclonal antibody, and the first and only biologic therapy to be approved simultaneously for the treatment of adults with moderately to severely active ulcerative colitis (UC) and adults with moderately to severely active Crohn's disease (CD) who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a tumor necrosis factor-alpha (TNFα) antagonist.
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is to establish 20 Collaborative Research Centres (CRCs) by 1 July 2012. This decision was taken by the Grants Committee at its spring session in Bonn. The new CRCs will receive funding totalling 176 million euros (including a 20 percent programme allowance for indirect project costs) for the initial 4-year funding period.
Elderly patients with limited-stage small cell lung cancer showed similar survival and toxicity compared to their younger counterparts when treated with concurrent chemo-radiotherapy. Concurrent chemo-radiotherapy should be a treatment option for fit patients aged 70 years or older.
Bayer HealthCare today announced updated data from the pivotal Phase III ALSYMPCA (ALpharadin in SYMptomatic Prostate CAncer) trial for its investigational drug radium-223 dichloride in men with castration-resistant prostate cancer (CRPC) and symptomatic bone metastases.
› Verified 3 days ago
| Entity Name | Epmg Downriver Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093085441 PECOS PAC ID: 6608038443 Enrollment ID: O20120424000499 |
News Archive
Cigarette smoking has been linked to acute myelogenous leukemia, according to The Health Consequences of Smoking: A Report of the Surgeon General, released today.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals International GmbH, today announced that the European Commission has granted Marketing Authorisation for Entyvio (vedolizumab), a gut-selective humanized monoclonal antibody, and the first and only biologic therapy to be approved simultaneously for the treatment of adults with moderately to severely active ulcerative colitis (UC) and adults with moderately to severely active Crohn's disease (CD) who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a tumor necrosis factor-alpha (TNFα) antagonist.
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is to establish 20 Collaborative Research Centres (CRCs) by 1 July 2012. This decision was taken by the Grants Committee at its spring session in Bonn. The new CRCs will receive funding totalling 176 million euros (including a 20 percent programme allowance for indirect project costs) for the initial 4-year funding period.
Elderly patients with limited-stage small cell lung cancer showed similar survival and toxicity compared to their younger counterparts when treated with concurrent chemo-radiotherapy. Concurrent chemo-radiotherapy should be a treatment option for fit patients aged 70 years or older.
Bayer HealthCare today announced updated data from the pivotal Phase III ALSYMPCA (ALpharadin in SYMptomatic Prostate CAncer) trial for its investigational drug radium-223 dichloride in men with castration-resistant prostate cancer (CRPC) and symptomatic bone metastases.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Benjamin Glines I, DO 615 N Michigan St, South Bend, IN 46601-1033 Ph: (574) 647-1000 | Benjamin Glines I, DO 615 N Michigan St, South Bend, IN 46601-1033 Ph: (574) 647-1000 |
News Archive
Cigarette smoking has been linked to acute myelogenous leukemia, according to The Health Consequences of Smoking: A Report of the Surgeon General, released today.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals International GmbH, today announced that the European Commission has granted Marketing Authorisation for Entyvio (vedolizumab), a gut-selective humanized monoclonal antibody, and the first and only biologic therapy to be approved simultaneously for the treatment of adults with moderately to severely active ulcerative colitis (UC) and adults with moderately to severely active Crohn's disease (CD) who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a tumor necrosis factor-alpha (TNFα) antagonist.
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is to establish 20 Collaborative Research Centres (CRCs) by 1 July 2012. This decision was taken by the Grants Committee at its spring session in Bonn. The new CRCs will receive funding totalling 176 million euros (including a 20 percent programme allowance for indirect project costs) for the initial 4-year funding period.
Elderly patients with limited-stage small cell lung cancer showed similar survival and toxicity compared to their younger counterparts when treated with concurrent chemo-radiotherapy. Concurrent chemo-radiotherapy should be a treatment option for fit patients aged 70 years or older.
Bayer HealthCare today announced updated data from the pivotal Phase III ALSYMPCA (ALpharadin in SYMptomatic Prostate CAncer) trial for its investigational drug radium-223 dichloride in men with castration-resistant prostate cancer (CRPC) and symptomatic bone metastases.
› Verified 3 days ago
Dr. Peter Ray Martin, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 715 Park Ave, South Bend, IN 46616 Phone: 574-536-4151 | |
Philip Richard Kavanagh, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 615 N Michigan St, South Bend, IN 46601 Phone: 574-647-7459 Fax: 574-647-3658 | |
Cheryl Wibbens, MD, MBA Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 615 N Michigan St, South Bend, IN 46601 Phone: 574-647-6525 Fax: 574-647-6691 | |
Dr. Aoko Doris Crain, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 615 N Michigan St, South Bend, IN 46601 Phone: 574-647-7459 Fax: 574-647-3658 | |
James Devereaux, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 801 E Lasalle Ave, South Bend, IN 46617 Phone: 574-282-8902 | |
Thomas Sweeney, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 615 N Michigan St, South Bend, IN 46601 Phone: 574-647-7459 Fax: 574-647-3658 |